Wednesday 2 December 2015

What are vaccine types? |


Definition

A vaccine is a suspension of immunogens (molecules that produce an immune
response or stimulate production of antibodies) such as weakened or dead
pathogenic (disease-causing) cells or cellular components. The act of
administering a vaccine, or immunization, is called vaccination. Persons who
receive a vaccine are considered immunized against a particular pathogen.
Vaccines may contain a pathogen, suspending fluid, adjuvants, excipients, and preservatives.




Several types of vaccines are given to humans. These types include live attenuated, inactivated, component or subunit, toxoid, conjugate, deoxyribonucleic acid (DNA), and recombinant vector vaccines. Live attenuated vaccines contain living but altered bacteria or viruses that do not cause disease. Inactivated or killed vaccines contain killed bacteria or inactivated viruses that do not cause disease. Component or subunit vaccines contain parts of the whole bacteria or viruses. Toxoid vaccines contain toxins (or poisons) produced by the pathogen that have been made harmless. Conjugate vaccines allow the immune system to recognize certain bacteria disguised by a polysaccharide outer coating and therefore respond. DNA and recombinant vector vaccines are in the experimental stage and both use genetic material to stimulate an antibody response.


Some vaccines are combinations of pathogens for different diseases, such as that for measles, mumps, and rubella (or MMR vaccine). Most vaccines are administered by injection into the muscle (intramuscular); however, some may be given into the skin (subcutaneous), by mouth, or into the nose (intranasal).


Active immunity is classified as natural (after pathogen exposure and
infection) or acquired (after vaccination). Passive immunity is also classified as natural (across the placenta
during pregnancy) or acquired (injection of antibodies or immunoglobulins pooled
from several donors). Immunoglobulins are prepared antibodies that are given to a
person who has already been infected or who is at risk of acquiring an infection,
thereby providing passive immunization. In this case, the immune system
does not need to produce antibodies protecting the body.



Herd immunity occurs when most of, but not all, the people in a given population are immune to a pathogen. If there is an outbreak or exposure to a pathogen, those who are immune will sometimes naturally protect those who are not immune from getting the disease; however, those who are not immune are still more likely to get the disease and spread it to others.




Mechanisms of Action

A vaccine is given to intentionally expose the immune system to a pathogen in a safe, controlled manner, so that the
immune system can react and develop antibodies to that pathogen or
antigen. Antibodies are large proteins that help fight infection and control
disease. Many antibodies disappear after destroying the invading antigens, but the
cells involved in antibody production remain and become memory cells. Memory cells “remember” the original antigen and then
defend against it if the antigen attempts to reinfect a person. This protection is
called immunity. Therefore, after sufficient antibodies have been developed,
the immune system that is re-exposed to that pathogen will react within minutes to
hours; the pathogen will be destroyed before a full-fledged infection and organ
damage can occur. B cells are a type of lymphocyte (white blood
cell) that makes antibodies. B cells use antibodies to
identify, inactivate, and help destroy these pathogens.


Vaccines, which provide protection from the disease without the serious symptoms, have a high effectiveness rate (usually 95 to 99 percent). Vaccine failure, meaning that the vaccine administration did not result in antibody production, is uncommon. Several factors can lead to vaccine failure, including having an already compromised immune system and the inadequate storage or administration of the vaccine. The immune response to a pathogen may decrease over time, so vaccines known as boosters are sometimes given to restore antibodies. Protective immunity lasts longer with boosters.


A suspending fluid (such as sterile water or saline) is needed to allow the
vaccine to be administered. Preservatives and stabilizers, such as albumin,
phenols, and glycine, keep the vaccine from being changed. Adjuvants, or
enhancers, help the vaccine work. Adjuvants help promote an earlier, more potent
response and a more persistent immune response to the vaccine. Antibiotics
prevent the growth of bacteria during production and storage of the vaccine. Eggs
are used to grow the pathogen, and egg protein is found in influenza and
yellow fever
vaccines. Formaldehyde is used to inactivate bacterial
products for toxoid vaccines and to kill unwanted viruses and bacteria that might
contaminate the vaccine during production. Monosodium glutamate and
2-phenoxy-ethanol are preservatives that help the vaccine remain unchanged during
the vaccine’s exposure to heat, light, acidity, or humidity. Thimerosal is a
mercury-containing preservative that helps prevent contamination and growth of
bacteria.


Most vaccines are given to prevent disease and are effective only if
administered to the person before he or she is exposed to the pathogen or disease;
most vaccines must be given by a certain age to ensure effectiveness. Also, most
vaccine-preventable diseases can cause serious or life-threatening infections in
infants and young children. For example, exposure and infection with
polio can occur at a very young age and can cause paralysis,
so the vaccine should be given to infants as soon as possible. Immunity to some
pathogens can be transferred from a pregnant woman to her fetus, but this immunity
wanes once the newborn is older than six months of age. Breast feeding can also
help extend immunity to some diseases, but even this is limited.


Certain vaccines (such as pneumococcal or hepatitis B vaccines) are given once in a lifetime, unless a booster is needed. The seasonal influenza vaccine, however, is given annually because hundreds of influenza-like viruses exist; also, the seasonal variations or types of virus that are prevalent change every year. Vaccination schedules have been developed for children, adolescents, and adults that indicate when these persons should receive doses of required vaccinations or boosters.




Vaccine Types

The selection of the type of vaccine depends on fundamental information or factors about the pathogen. These factors include how the pathogen infects cells and how the immune system responds to it. Practical considerations include the regions of the world where the vaccine would be used. Pros and cons are associated with each type of vaccine.



Live attenuated vaccines. Live attenuated vaccines are usually created from the naturally occurring pathogen. The pathogen’s ability to cause serious infection is attenuated, or weakened, by manipulating the virus or bacteria in a laboratory environment, but these vaccines can still induce antibody production or a protective immune response. Attenuation of the pathogen usually is done by “passing” or growing the virus or bacteria from culture to culture before it is formulated into a vaccine. Live attenuated vaccines elicit strong cellular and antibody responses and often confer lifelong immunity with only one or two doses. Not everyone can safely receive live attenuated vaccines, however. People with weakened immune systems cannot be given live vaccines because of the risk they will develop disease symptoms.


These types of vaccines usually need to be refrigerated to stay potent. Proper storage then becomes critical in maintaining vaccine efficacy. Examples of live attenuated vaccines include measles, mumps, and rubella (MMR vaccine), oral polio vaccine (OPV), the nasal form of the influenza (flu) vaccine, and the varicella vaccine (chickenpox vaccine).



Inactivated vaccines. Inactivated vaccines contain a killed pathogen that cannot cause the disease but can stimulate antibody production. Pathogens can be inactivated with chemicals such as formaldehyde. Inactivated vaccines are more stable and safer than live vaccines. These vaccines usually do not require refrigeration and are easily stored and transported in freeze-dried form, making them useful in situations requiring long transportation or with less-developed medical infrastructure. Most inactivated vaccines, however, produce a weaker immune response than do live vaccines. Several additional doses or booster shots, therefore, are needed to maintain immunity. Examples of inactivated vaccines include inactivated polio vaccine (IPV) and inactivated (injectable form) influenza vaccine.



Component or subunit vaccines. Component or subunit
vaccines are made by using only parts of the pathogen. These vaccines
cannot cause disease, but they can stimulate the body to produce an immune
response against the disease. Component vaccines contain only the essential
antigens, but not all the other molecules, of the pathogen, so the chance of an
adverse reaction to the vaccine is lessened.


These vaccines can contain anywhere from one to twenty or more antigens.
Identifying what antigens best stimulate the immune system can be a tricky,
time-consuming process. A recombinant component vaccine has been created for the
hepatitis
B virus. Hepatitis B genes that code for important antigens
were inserted into common baker’s yeast. The yeast then produced the antigens,
which were collected and purified for use in the vaccine.


A conjugate vaccine is another type of component vaccine that has been developed for bacterium that possesses an outer coating of sugar molecules called polysaccharides. The polysaccharide coating disguises the internal antigens of the bacterium so that the immune system does not recognize or respond to it. Vaccines help the immune system link the polysaccharide coating to the bacterium and, therefore, allow antibodies to produce immunity to that pathogen. Examples of component vaccines include Haemophilus influenzae type B (Hib) vaccine, hepatitis B (Hep B) vaccine, hepatitis A (Hep A) vaccine, and pneumococcal conjugate vaccine.



Toxoid vaccines. Toxoid
vaccines are made by treating the toxin produced by the pathogen with
heat or chemicals, such as formalin (a solution of formaldehyde and sterilized
water). For pathogens that secrete toxins or harmful chemicals, a toxoid vaccine
may be used when the toxoid is the main cause of illness. Toxins are inactivated
and do not produce disease. Detoxified toxins are called toxoids. After
vaccination with a toxoid vaccine, the immune system produces antibodies that
block the toxin. Examples of toxoid vaccines include those against
diphtheria and tetanus.



DNA vaccines. DNA
vaccines, which are experimental, contain the genes that code for antigens. This requires that the genes from the pathogen be analyzed. DNA vaccines would stimulate an immune response to the free-floating antigen secreted by cells and would stimulate a response against the antigens displayed on cell surfaces. DNA vaccines would contain copies of a few of the pathogen’s genes, so the vaccine would not cause disease.


DNA vaccines are relatively easy and inexpensive to design and produce. Naked DNA vaccines, which consist of DNA that is administered directly into the body, could be mixed with molecules that facilitate its uptake by the body’s cells. Naked DNA vaccines for influenza and herpesviruses are being investigated.



Recombinant vector vaccines. Recombinant vector vaccines, also experimental, use an attenuated pathogen to introduce DNA to cells of the body. A vector in this case is a harmless virus or bacterium used as a carrier. Certain harmless or attenuated viruses are used to carry portions of the genetic material from other microbes. The carrier viruses then ferry the microbial DNA to cells and display the antigens of the pathogen on the cell’s surface. The harmless organism mimics a pathogen and provokes an immune response. Recombinant vector vaccines closely mimic a natural infection, effectively stimulating the immune system. Recombinant vector vaccines for human immunodeficiency virus (HIV), rabies, and measles are under investigation.




Controversy

State laws in the United States mandate that children in day care and students
be immunized against certain diseases. Some exceptions are allowed. Still, many
parents are refusing to immunize their children for fear of a link between
autism, for example, and the use of vaccines containing thimerosal, a mercury-based preservative. Although scientific
evidence does not support this link, thimerosal is no longer used in the
production of most vaccines in the United States. To alert persons to adverse
effects associated with vaccine administration, and to educate parents and others
about what to expect after receiving a vaccine, an information sheet must be given
to each person before he or she can be vaccinated.




Impact

Disease prevention is the key to public health, and it is always better to prevent a disease than to have to treat it. Vaccination is considered one of the most important medical discoveries in all of human history. Diseases can cause suffering, permanent disability, and death. Vaccines prevent disease in those who get vaccinated and protect those who come into contact with unvaccinated persons. Vaccination has controlled many infectious diseases that were once common, including polio, measles, diphtheria, pertussis (whooping cough), rubella (German measles), mumps, tetanus, and influenza. It even led to the complete eradication of smallpox from the human population.


Not all countries have the same level of vaccination requirements as the United States. Given the current global nature of travel and business, exposure to many diseases is likely. Vaccination minimizes the risk of developing a disease and its associated complications. When persons travel outside the United States, additional vaccinations may be needed. One should consult a physician within a minimum of four weeks of traveling to determine what vaccines, if any, are needed.




Bibliography


Centers for Disease Control and Prevention. “General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices.” Morbidity and Mortality Weekly Report 55 (December 1, 2006): 1-48. Print.



Centers for Disease Control and Prevention. “Immunization Schedules.” Available at http://www.cdc.gov/vaccines/recs/schedules.



Centers for Disease Control and Prevention. “Understanding the Basics: General Recommendations on Immunization.” Available at http://www2a.cdc.gov/nip/isd/ycts/mod1/courses/genrec/10300.asp.



Merino, Noël. Vaccines. Farmington Hills: Greenhaven, 2015. Print.



Plotkin, Stanley A., Walter A. Orenstein, and Paul A. Offit. Vaccines. 5th ed. Philadelphia: Saunders/Elsevier, 2008. Print.



Shoenfeld, Yehuda, and Nancy Agmon-Levin. Vaccines and Autoimmunity. Hoboken: Wiley, 2015.



"Types of Vaccines." National Institute of Allergy and Infectious Disease. National Institutes of Health, 3 Apr. 2012. Web. 31 Dec. 2015.

No comments:

Post a Comment

How can a 0.5 molal solution be less concentrated than a 0.5 molar solution?

The answer lies in the units being used. "Molar" refers to molarity, a unit of measurement that describes how many moles of a solu...